These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16321526)

  • 1. Antiarrhythmic activity of 4,6-di(het)aryl-5-nitro-3,4-dihydropyrimidin-(1H)-2-ones and its effects on arterial pressure in rats.
    Bryzgalov AO; Dolgikh MP; Sorokina IV; Tolstikova TG; Sedova VF; Shkurko OP
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1418-20. PubMed ID: 16321526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-(Arylamino)-6,7-dihydro-6-methylpyrano[4,3-c]pyrazol-4(1H or 2H)-ones with antipyretic, analgesic, antiarrhythmic, hypotensive and other activities.
    Bruno O; Ranise A; Schenone S; Bondavalli F; D'amico M; Falciani M; Berrino L; Rossi F
    Farmaco; 1993 Dec; 48(12):1697-708. PubMed ID: 8135993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 6-thiosubstituted 5-ethoxycarbonyl-1,3-diphenyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-ones, 6-substituted 5-hydroxy-1,3-diphenyl-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-ones and their esters with local anesthetic, antiarrhythmic, antiinflammatory and analgesic activities.
    Ranise A; Bruno O; Schenone S; Bondavalli F; Falcone G; Filippelli W; Sorrentino S
    Farmaco; 1997; 52(8-9):547-55. PubMed ID: 9507663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic profile and endothelial action of novel decahydroquinoline derivatives.
    Kozlovski VI; Vdovichenko VP; Chlopicki S; Malchik SS; Praliyev KD; Zcilkibayev OT
    Pol J Pharmacol; 2004; 56(6):767-74. PubMed ID: 15662089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular activity of the chiral xanthone derivatives.
    Szkaradek N; Rapacz A; Pytka K; Filipek B; Żelaszczyk D; Szafrański P; Słoczyńska K; Marona H
    Bioorg Med Chem; 2015 Oct; 23(20):6714-24. PubMed ID: 26386822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic activity of oximethers.
    Hegedüs M; Petöcz L; Budai Z; Mezei T
    Acta Physiol Hung; 1995; 83(3):223-6. PubMed ID: 8852647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [2-(2'-hydroxy 2'-substituted) ethyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazines--a novel group of substances with anti-arrhythmia activity].
    Filippova OV; Kryzhanovskiĭ SA; Peresada VP; Likhosherstov AM; Vititnova MB; Kaverina NV; Reznikov KM
    Eksp Klin Farmakol; 2003; 66(3):21-5. PubMed ID: 12924227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Maciag D; Filipek B; Malawska B
    Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic and antihypertensive activity of some xanthone derivatives.
    Marona H; Librowski T; Cegła M; Erdoğan C; Sahin NO
    Acta Pol Pharm; 2008; 65(3):383-90. PubMed ID: 18646559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiarrhythmic properties of basic amide derivatives of imidazolidine-2,4-dione and pyrrolidine-2,5-dione II.
    Kieć-Kononowicz K; Byrtus H; Zejc A; Filipek B; Chevallet P
    Farmaco; 1995 May; 50(5):355-60. PubMed ID: 7626171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of new benzofurane, benzopiran and furanochromone derivatives--potential antiarrhythmic and hypotensive agents.
    Jedrych Z; Borkowska G
    Pol J Pharmacol Pharm; 1983; 35(5):397-403. PubMed ID: 6664941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agents.
    Piatnitski Chekler EL; Butera JA; Di L; Swillo RE; Morgan GA; Rossman EI; Huselton C; Larsen BD; Hennan JK
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4551-4. PubMed ID: 19616941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and cardiovascular activity of new 8-alkylamino-1,3-dimethyl-7-(2-hydroxy-3- piperazinopropyl)-3,7-dihydro-1H-purine-2,6-diones.
    Chłoń-Rzepa G; Pawłowski M; Zygmunt M; Filipek B; Maciag D
    Pol J Pharmacol; 2004; 56(6):755-66. PubMed ID: 15662088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and properties of some aryloxyaminoalkanes.
    Marona H; Gajewczyk L; Filipek B
    Acta Pol Pharm; 1996; 53(1):47-52. PubMed ID: 8960283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavonoids from Chinese Viscum coloratum: antiarrhythmic efficacy and ionic mechanisms.
    Wen-Feng C; Guo-Fen Q; Yan-Jie L; Zhen-Wei P; Xian-Mei P; Yun-Long B; Hong-Li S; Bao-Feng Y
    Phytother Res; 2006 Dec; 20(12):1100-2. PubMed ID: 17013818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive and antiarrhythmic properties of a para-hydroxy[bis(ortho-morpholinylmethyl)]phenyl-1,4-DHP compound: comparison with other compounds of the same kind and relationship with logP values.
    Abrego VH; Martínez-Pérez B; Torres LA; Angeles E; Martínez L; Marroquín-Pascual JL; Moya-Hernández R; Amaro-Recillas HA; Rueda-Jackson JC; Rodríguez-Barrientos D; Rojas-Hernández A
    Eur J Med Chem; 2010 Oct; 45(10):4622-30. PubMed ID: 20705371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological activity of some N,N-disubstituted 1-amino-2-phenyl-3H,12H-naphtho[1,2-b]pyrano[2,3-d]pyran-3-ones.
    Longobardi M; Bargagna A; Mariani E; Filippelli W; Falcone G; Marabese I
    Farmaco; 1996 Oct; 51(10):665-8. PubMed ID: 8981757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and antiarrhythmic properties of protamine in rats.
    Pugsley MK; Kalra V; Froebel-Wilson S; Aardalen K
    Proc West Pharmacol Soc; 2001; 44():33-6. PubMed ID: 11793988
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors.
    Atwal KS; O'Neil SV; Ahmad S; Doweyko L; Kirby M; Dorso CR; Chandrasena G; Chen BC; Zhao R; Zahler R
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4796-9. PubMed ID: 16870436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.